Kneeland Elizabeth, Ali Nadia, Maislin David G, Chang Yoon Hee, Epelboim Joyce, Keenan Brendan T, Pack Allan I
Kneeland Consulting, Philadelphia, PA, USA.
Division of Sleep Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
ERJ Open Res. 2024 Dec 2;10(6). doi: 10.1183/23120541.00132-2024. eCollection 2024 Nov.
Obstructive sleep apnoea (OSA) is common in commercial drivers, and associated with increased risk of crashes if untreated, making diagnosis and effective treatment crucial in this population.
This is a retrospective summary of a clinical programme based on telemedicine and remote treatment monitoring developed with a national trucking company to screen new hires in the USA for OSA and implement positive airway pressure (PAP) management. New hires were informed of the programme and consented as part of their employment. Drivers who did not comply with the evaluation or with PAP after diagnosis were removed from driving commercial vehicles by the company or did not pursue further employment.
A total of 975 drivers were enrolled. Among screened drivers, 35.5% were cleared without a sleep study, 15.0% were cleared following a sleep study (apnoea-hypopnoea index (AHI) <5 events·h), 22.1% had mild OSA (AHI 5-15) and 27.4% had moderate-severe OSA (AHI ≥15). Those with moderate-severe OSA were more obese (body mass index 36.2±6.3 kg·m) and had more comorbidities. Of 269 drivers starting PAP, 160 (59.5%) maintained participation in a care management programme, 80 (29.7%) resigned or were terminated, 23 (8.6%) were cleared to discontinue PAP and six (2.2%) were complex cases requiring transfer of care. Illustrating effectiveness, those that maintained participation had excellent PAP adherence (5.27±1.61 h·night; 88.5±12.9% days used; 79.7±17.7% days used ≥4 h).
Remote assessment of OSA and PAP management in commercial drivers is feasible and effective. This approach has wide-ranging applications, particularly in populations and areas with a lack of sleep medicine providers.
阻塞性睡眠呼吸暂停(OSA)在商业驾驶员中很常见,如果不治疗,会增加撞车风险,因此在这一人群中进行诊断和有效治疗至关重要。
这是一项基于远程医疗和远程治疗监测的临床项目的回顾性总结,该项目是与一家美国全国性货运公司合作开展的,旨在对美国新入职员工进行OSA筛查并实施气道正压通气(PAP)管理。新入职员工被告知该项目,并作为其入职的一部分表示同意。未遵守评估或诊断后未使用PAP的驾驶员被公司禁止驾驶商用车或未继续工作。
共招募了975名驾驶员。在接受筛查的驾驶员中,35.5%未经睡眠研究即被排除,15.0%经睡眠研究后被排除(呼吸暂停低通气指数(AHI)<5次/小时),22.1%患有轻度OSA(AHI 5-15),27.4%患有中度至重度OSA(AHI≥15)。中度至重度OSA患者更肥胖(体重指数36.2±6.3kg/m²)且合并症更多。在开始使用PAP的269名驾驶员中,160名(59.5%)继续参与护理管理项目,80名(29.7%)辞职或被解雇,23名(8.6%)被批准停止使用PAP,6名(2.2%)为复杂病例需要转诊。表明有效性的是,继续参与的患者对PAP的依从性极佳(5.27±1.61小时/晚;88.5±12.9%的天数使用;79.7±17.7%的天数使用≥4小时)。
对商业驾驶员进行OSA远程评估和PAP管理是可行且有效的。这种方法具有广泛的应用,特别是在缺乏睡眠医学服务提供者的人群和地区。